Cardiovascular Health — Race & Medicine

In development…

Carlos Rodriguez, MD, MPH presents on Cardiovascular Disease - Health Disparities in Underrepresented Minorities. He is recognized as a national leader in the study of cardiovascular risk factors that affect minorities, his research focus includes hypertensive heart disease, heart failure, bio-behavioral cardiovascular health, cardiovascular epidemiology and cardiovascular health disparities.

Resources

Beatty Moody DL, Leibel DK, Pantesco EJ, et al. Interactive relations across dimensions of interpersonal-level discrimination and depressive symptoms to carotid intimal-medial thickening in African Americans. Psychosom Med 2020; 82: 234-246.

Casey SD, Mumma BE. Sex, race, and insurance status differences in hospital treatment and outcomes following out-of-hospital cardiac arrest. Resuscitation. 2018; 126: 125‐129.

Esenwa C, Ilunga Tshiswaka D, Gebregziabher M, Ovbiagele B. Historical slavery and modern-day stroke mortality in the United States stroke belt. Stroke. 2018; 49: 465-469.

Essien UR, Holmes DN, Jackson LR 2nd, et al. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II. JAMA Cardiol. 2018; 3 (12): 1174-1182.

Essien UR, Magnani JW, Chen N, Gellad WF, Fine MJ, Hernandez I. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data. J Natl Med Assoc. 2020; 112 (1): 103-108.

Essien UR, Jackson LR 2nd. Race Effects in CVD Prediction Models. J Gen Intern Med. 2019; 34 (4): 484.

Fincher C, Williams JE, MacLean V, Allison JJ, Kiefe CI, Canto J. Racial disparities in coronary heart disease: a sociological view of the medical literature on physician bias. Ethn Dis. 2004; 14 (3): 360‐371.

Gauri AJ, Davis A, Hong T, et al. Disparities in the use of primary prevention and defibrillator therapy among blacks and women. Am J Med. 2006; 119: 167.e17–167.e21.

Groeneveld PW, Heidenreich PA, Garber AM. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest. Circulation. 2003; 108 (3): 286‐291.

Hernandez AF, Fonarow GC, Liang L, et al. Sex and racial differences in the use of implantable cardioverter‐defibrillators among patients hospitalized with heart failure. JAMA. 2007;298:1525–1532.

Ifidon AM, Agbalajobi O, Essien UR. Improving Racial and Ethnic Minority Representation in Cardiovascular Disease Trials to Advance Health Equity [published online ahead of print, 2020 Mar 4]. JAMA Cardiol. 2020; 10.1001/jamacardio.2020.0167.

Jha AK, Fisher ES, Li Z, et al. Racial trends in the use of major procedures among the elderly. N Engl J Med. 2005; 353: 683–691.

Kramer MR, Black NC, Matthews SA, James SA. Population health: the legacy of slavery and contemporary declines in heart disease mortality in the US south. SSM-Popul Health. 2017; 3: 609-617.

LaVeist TA, Nickerson KJ, Bowie JV. Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev 2000; 57: Suppl 1: 146-161.

Lukachko A, Hatzenbuehler ML, Keyes KM. Structural racism and myocardial infarction in the United States. Soc Sci Med. 2014; 103: 42‐50.

Paulus JK, Wessler BS, Lundquist CM, Kent DM. Effects of Race Are Rarely Included in Clinical Prediction Models for Cardiovascular Disease. J Gen Intern Med. 2018; 33 (9): 1429-1430.

Peterson ED, Wright SM, Daley J, et al. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA. 1994;271:1175–1180.

Sullivan LT, Randolph T, Merrill P, et al. Representation of black patients in randomized clinical trials of heart failure with reduced ejection fraction. Am Heart J. 2018; 197: 43–52.

Taylor AL. Importance of Race/Ethnicity in Clinical Trials: Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) Circulation. 2005; 112 (23): 3654–3666.

Thomas KL, Al-Khatib SM, Kelsey RC 2nd, et al. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of ≤35%. Am J Cardiol. 2007; 100 (6): 924‐929.

Verma AA, Jimenez MP, Subramanian SV, et al. Race and Socioeconomic Differences Associated With Changes in Statin Eligibility Under the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines. Circ Cardiovasc Qual Outcomes. 2017; 10 (9): e003764.

Wyatt SB, Williams DR, Calvin R, Henderson FC, Walker ER, Winters K. Racism and cardiovascular disease in African Americans. Am J Med Sci. 2003; 325 (6): 315‐331.